trending Market Intelligence /marketintelligence/en/news-insights/trending/aXPWbKmGMxdOeWeuQ6zXww2 content esgSubNav
In This List

IRDAI approves Max India's stake divestment in Max Bupa

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


IRDAI approves Max India's stake divestment in Max Bupa

The Insurance Regulatory and Development Authority of India approved True North Fund VI LLP's purchase of Max India Ltd.'s 51% stake in Max Bupa Health Insurance Co. Ltd.

Max India announced the all-cash transaction in February. The acquisition, which is now set to close within the next few weeks, valued Max Bupa at an enterprise value of 10.01 billion rupees.

Max Bupa is a joint venture between U.K.-based Bupa and Max India.

As of Dec. 2, US$1 was equivalent to 71.66 Indian rupees.